Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advanced Healthcare Materials|May 22, 2026
Electroactive Nanomaterials in Tissue Engineering: Advances, Mechanisms and Future PerspectivesHuina He, Shuran Chen, Qiang Peng
Frontiers in Immunology|March 6, 2026
Integrating multi-omics and machine learning to unravel mechanisms of lymph node metastasis in papillary carcinoma with and without thyroiditisShuran Chen, Wencan Yang, Yanyan Liu, et al.
Cancer Reports (Hoboken, N.J.)|June 26, 2024
SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMTZhenghong Le, Shuran Chen, Yan Feng, et al.
Plos One|June 7, 2022
GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathwayFei Lu, Shuran Chen, Weijun Shi, et al.
Clinical and Experimental Medicine|May 20, 2026
PFAS is associated with perineural invasion in triple-negative breast cancer with a potential role for Cathepsin D dysregulation: a multi-omics and experimental studyShuran Chen, Rongsheng Su, Zhenglang Yin, et al.
Scientific Reports|June 24, 2026
Clofibrate downregulates DNA damage response proteins via the MELK-AKT-mTOR axis in breast cancerHaohao Chen, Wencan Yang, Zhenglang Ying, et al.
Cancer Pathogenesis and Therapy|September 26, 2023
Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesisLaYow C Yu, Danielle D Dang, Sophie Zhuang, et al.
Frontiers in Oncology|August 15, 2022
Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing AnalysisShuran Chen, Xu Su, Jing Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 8, 2025
rWTC-MBTA Vaccine, Alone and Enhanced with Anti-PD1, Elicits Immune Responses against CNS and Peripheral B-Cell LymphomaYaping Zhang, Juan Ye, Mitchell Sun, et al.
Frontiers in Genetics|June 27, 2022
m7G-Related DNA Damage Repair Genes are Potential Biomarkers for Predicting Prognosis and Immunotherapy Effectiveness in Colon Cancer PatientsShuran Chen, Rui Dong, Yan Li, et al.
Pageof 2